Eagle Global Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-131,237
| Closed | -$335K | – | 302 |
|
|
2017
Q2 | $335K | Sell |
131,237
-25,039
| -16% | -$63.9K | 0.01% | 283 |
|
|
2017
Q1 | $406K | Hold |
156,276
| – | – | 0.01% | 240 |
|
|
2016
Q4 | $477K | Hold |
156,276
| – | – | 0.01% | 218 |
|
|
2016
Q3 | $425K | Sell |
156,276
-15,083
| -9% | -$41K | 0.01% | 223 |
|
|
2016
Q2 | $490K | Buy |
171,359
+35,161
| +26% | +$101K | 0.01% | 196 |
|
|
2016
Q1 | $411K | Buy |
136,198
+19,250
| +16% | +$58.1K | 0.01% | 223 |
|
|
2015
Q4 | $406K | Buy |
116,948
+38,159
| +48% | +$132K | 0.01% | 232 |
|
|
2015
Q3 | $298K | Buy |
78,789
+67,039
| +571% | +$254K | 0.01% | 274 |
|
|
2015
Q2 | $67K | Sell |
11,750
-14,450
| -55% | -$82.4K | ﹤0.01% | 376 |
|
|
2015
Q1 | $152K | Buy |
+26,200
| New | +$152K | ﹤0.01% | 329 |
|